PG changes
Pick any two versions below to diff them.
- Price
- $151.23 → $159.35(+5.4%)
- Discount
- 2.4% → -2.8%(−5.2 pts)
- LSEG rating
- 2.54 → 2.48(−0.06)
- Recent events
- 2026-10-13: At the annual meeting, shareholders elected all 12 director nominees and voted against three shareholder proposals, per preliminary results. The board declared a quarterly dividend of $1.0885 per share, payable on or after November 16, 2026. 2026-09-24: P&G confirmed that it will discuss its fiscal first-quarter 2027 results on October 22, 2026. 2026-08-04: P&G agreed to buy Thorne, a maker of premium vitamins and supplements, for $3.8 billion in cash. Thorne will join the Health Care segment. P&G expects the purchase to close between October and December 2026, after regulatory approvals. 2026-07-29: P&G reported fiscal 2026 results. Net sales were $87.0 billion, organic sales grew 1%, and core EPS was $6.89. All of the organic growth came from price, and volume was flat. For fiscal 2027, P&G guided organic sales growth of 1% to 3% and core EPS of $6.89 to $7.11, and it expects first-quarter core EPS to fall 5% or more. 2026-07-29: P&G's board named CEO Shailesh Jejurikar as Chairman, effective August 1, 2026. He succeeds Jon Moeller, who retired from the board on July 31, 2026, and from the company on August 14, 2026. 2026-04-14: P&G raised its quarterly dividend by 3% to $1.0885 per share. This is its 70th annual dividend increase in a row. 2025-06-05: P&G announced a two-year restructuring plan to cut about 7,000 non-manufacturing jobs, about 6% of its total workforce, and to exit some brands and categories.